Jamjoom Pharma, Viatris pen local manufacturing agreement

24/04/2026 Argaam
Logo ofJamjoom Pharma

Logo of Jamjoom Pharma

Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) signed a local manufacturing agreement with Viatris Arabia Ltd., a subsidiary of the global healthcare company Viatris.

 

Under the partnership, Jamjoom Pharma will manufacture several products across multiple therapeutic areas from Viatris’ portfolio, which are made available to patients in Saudi Arabia.

 

The company said the agreement aligns with Saudi Vision 2030 objectives by enhancing local manufacturing capabilities and contributing to sustainable access to high-quality medicines for patients across the Kingdom.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.